Ledger.Open graph →
SEC Form D · filed June 19, 2019

Remiges BioPharma Fund II, LP

Offering
$95.0M
Sold
—
Exemption
Rule 506(b)
Industry
Pooled Investment Fund
Location
CAMBRIDGE, MA
Type
Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Taro Inaba · Chiyoda-ku, Tokyo, M0DirectorRemiges Biopharma Fund Gp Ii, Inc · Cambridge, MAExec · DirectorMichael B. Lazar · Greenwich, CTDirectorWalter Olesiak · CAMBRIDGE, MADirectorTracy Caswell · Atlanta, GADirectorRemiges Biopharma Fund Gp Ii, Inc · Cambridge, MAExec · DirectorWalter Olesiak · CAMBRIDGE, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗